Sequencing of noncrossresistant agents

Comment

J H Goldie. J Clin Oncol. 1991 Aug.

. 1991 Aug;9(8):1513-4.

doi: 10.1200/JCO.1991.9.8.1513.

No abstract available

Comment on

A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin.
Fukuoka M, Masuda N, Furuse K, Negoro S, Takada M, Matsui K, Takifuji N, Kudoh S, Kawahara M, Ogawara M, et al. Fukuoka M, et al. J Clin Oncol. 1991 Apr;9(4):606-13. doi: 10.1200/JCO.1991.9.4.606. J Clin Oncol. 1991. PMID: 1648597 Clinical Trial.
Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients.
Wolf M, Pritsch M, Drings P, Hans K, Schroeder M, Flechtner H, Heim M, Hruska D, Mende S, Becker H, et al. Wolf M, et al. J Clin Oncol. 1991 Apr;9(4):614-24. doi: 10.1200/JCO.1991.9.4.614. J Clin Oncol. 1991. PMID: 1648598 Clinical Trial.